SG11201505867PA - Pyridine derivatives as soft rock inhibitors - Google Patents
Pyridine derivatives as soft rock inhibitorsInfo
- Publication number
- SG11201505867PA SG11201505867PA SG11201505867PA SG11201505867PA SG11201505867PA SG 11201505867P A SG11201505867P A SG 11201505867PA SG 11201505867P A SG11201505867P A SG 11201505867PA SG 11201505867P A SG11201505867P A SG 11201505867PA SG 11201505867P A SG11201505867P A SG 11201505867PA
- Authority
- SG
- Singapore
- Prior art keywords
- pyridine derivatives
- soft rock
- rock inhibitors
- inhibitors
- soft
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/4353—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems
- A61K31/4355—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom ortho- or peri-condensed with heterocyclic ring systems the heterocyclic ring system containing a five-membered ring having oxygen as a ring hetero atom
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P15/00—Drugs for genital or sexual disorders; Contraceptives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D273/00—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00
- C07D273/01—Heterocyclic compounds containing rings having nitrogen and oxygen atoms as the only ring hetero atoms, not provided for by groups C07D261/00 - C07D271/00 having one nitrogen atom
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| EP13153094 | 2013-01-29 | ||
| GB201303494A GB201303494D0 (en) | 2013-02-27 | 2013-02-27 | Novel soft rock inhibitors |
| PCT/EP2014/051546 WO2014118133A1 (en) | 2013-01-29 | 2014-01-27 | Pyridine derivatives as soft rock inhibitors |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201505867PA true SG11201505867PA (en) | 2015-08-28 |
Family
ID=50112877
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201505867PA SG11201505867PA (en) | 2013-01-29 | 2014-01-27 | Pyridine derivatives as soft rock inhibitors |
Country Status (24)
| Country | Link |
|---|---|
| US (2) | US9682963B2 (pt) |
| EP (1) | EP2951172B8 (pt) |
| KR (1) | KR102275616B1 (pt) |
| CN (1) | CN105026387B (pt) |
| AU (1) | AU2014211580B2 (pt) |
| BR (1) | BR112015018168B1 (pt) |
| CA (1) | CA2898674C (pt) |
| CY (1) | CY1119227T1 (pt) |
| DK (1) | DK2951172T3 (pt) |
| EA (1) | EA029653B1 (pt) |
| ES (1) | ES2629762T3 (pt) |
| HK (1) | HK1215706A1 (pt) |
| HR (1) | HRP20170940T1 (pt) |
| HU (1) | HUE033962T2 (pt) |
| IL (1) | IL240363B (pt) |
| LT (1) | LT2951172T (pt) |
| MX (1) | MX367818B (pt) |
| NZ (1) | NZ711424A (pt) |
| PL (1) | PL2951172T3 (pt) |
| PT (1) | PT2951172T (pt) |
| RS (1) | RS56089B1 (pt) |
| SG (1) | SG11201505867PA (pt) |
| SI (1) | SI2951172T1 (pt) |
| WO (1) | WO2014118133A1 (pt) |
Families Citing this family (19)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JOP20190024A1 (ar) | 2016-08-26 | 2019-02-19 | Gilead Sciences Inc | مركبات بيروليزين بها استبدال واستخداماتها |
| TWI800498B (zh) | 2016-12-21 | 2023-05-01 | 義大利商吉斯藥品公司 | 作為Rho-激酶抑制劑之雙環二氫嘧啶-羧醯胺衍生物 |
| WO2018138293A1 (en) | 2017-01-30 | 2018-08-02 | Chiesi Farmaceutici S.P.A. | Tyrosine amide derivatives as rho- kinase inhibitors |
| US11542256B2 (en) | 2017-09-03 | 2023-01-03 | Angion Biomedica Corp. | Vinylheterocycles as Rho-associated coiled-coil kinase (ROCK) inhibitors |
| MA50074A (fr) | 2017-09-07 | 2021-04-28 | Chiesi Farm Spa | Dérivés d'analogues de tyrosine en tant qu'inhibiteurs de rho-kinase |
| WO2019121233A1 (en) | 2017-12-18 | 2019-06-27 | Chiesi Farmaceutici S.P.A. | Oxadiazole derivatives as rho-kinase inhibitors |
| US11725007B2 (en) | 2017-12-18 | 2023-08-15 | Chiesi Farmaceutici S.P.A. | Meta tyrosine derivatives as rho-kinase inhibitors |
| US11332468B2 (en) | 2017-12-18 | 2022-05-17 | Chiesi Farmaceutici S.P.A. | Azaindole derivatives as Rho-kinase inhibitors |
| CN111788204B (zh) | 2018-02-26 | 2023-05-05 | 吉利德科学公司 | 作为hbv复制抑制剂的取代吡咯嗪化合物 |
| AR114926A1 (es) | 2018-06-13 | 2020-10-28 | Chiesi Farm Spa | Derivados de azaindol como inhibidores de rho-quinasa |
| TW202019923A (zh) | 2018-07-16 | 2020-06-01 | 義大利商吉斯藥品公司 | 作為Ｒｈｏ－激酶抑制劑之酪胺酸醯胺衍生物 |
| CN110917352A (zh) * | 2019-10-22 | 2020-03-27 | 天津医科大学肿瘤医院 | Rock抑制剂在肿瘤免疫治疗中的新用法 |
| IL293592A (en) | 2019-12-06 | 2022-08-01 | Vertex Pharma | Transduced tetrahydrofurans as sodium channel modulators |
| EP4263549A1 (en) | 2020-12-15 | 2023-10-25 | Chiesi Farmaceutici S.p.A. | Dihydrofuropyridine derivatives as rho-kinase inhibitors |
| MX2023005865A (es) | 2020-12-15 | 2023-06-05 | Chiesi Farm Spa | Derivados de dihidrofuropiridina como inhibidores de rho-cinasa. |
| US20240082223A1 (en) | 2020-12-15 | 2024-03-14 | Chiesi Farmaceutici S.P.A. | Dihydrofuropyridine derivatives as rho- kinase inhibitors |
| AR126073A1 (es) | 2021-06-04 | 2023-09-06 | Vertex Pharma | N-(hidroxialquil(hetero)aril)tetrahidrofuran carboxamidas como moduladores de canales de sodio |
| WO2023110700A1 (en) | 2021-12-13 | 2023-06-22 | Chiesi Farmaceutici S.P.A. | Dihydrofuropyridine derivatives as rho-kinase inhibitors |
| WO2024052704A1 (en) | 2022-09-08 | 2024-03-14 | Redx Pharma Plc | Solid forms of a rock inhibitor |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IS2334B (is) | 1992-09-08 | 2008-02-15 | Vertex Pharmaceuticals Inc., (A Massachusetts Corporation) | Aspartyl próteasi hemjari af nýjum flokki súlfonamíða |
| US6043358A (en) | 1995-11-01 | 2000-03-28 | Merck & Co., Inc. | Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| GB9718913D0 (en) | 1997-09-05 | 1997-11-12 | Glaxo Group Ltd | Substituted oxindole derivatives |
| US6369087B1 (en) | 1999-08-26 | 2002-04-09 | Robert R. Whittle | Alkoxy substituted benzimidazole compounds, pharmaceutical preparations containing the same, and methods of using the same |
| CN101248046A (zh) * | 2005-07-11 | 2008-08-20 | 德福根有限公司 | 作为激酶抑制剂的酰胺衍生物 |
| JP2009511529A (ja) * | 2005-10-13 | 2009-03-19 | デブジェン エヌブイ | キナーゼ阻害剤 |
| PT2542528E (pt) * | 2010-03-02 | 2013-09-09 | Amakem Nv | Aminas heterociclicas como inibidores rock |
| GB201114854D0 (en) | 2011-08-29 | 2011-10-12 | Amakem Nv | Novel rock inhibitors |
| EP2751079A1 (en) | 2011-08-31 | 2014-07-09 | Amakem NV | Biphenylcarboxamides as rock kinase inhibitors |
-
2014
- 2014-01-27 HU HUE14704532A patent/HUE033962T2/en unknown
- 2014-01-27 LT LTEP14704532.2T patent/LT2951172T/lt unknown
- 2014-01-27 DK DK14704532.2T patent/DK2951172T3/en active
- 2014-01-27 CA CA2898674A patent/CA2898674C/en active Active
- 2014-01-27 NZ NZ711424A patent/NZ711424A/en unknown
- 2014-01-27 SI SI201430261T patent/SI2951172T1/sl unknown
- 2014-01-27 MX MX2015009674A patent/MX367818B/es active IP Right Grant
- 2014-01-27 AU AU2014211580A patent/AU2014211580B2/en active Active
- 2014-01-27 KR KR1020157023210A patent/KR102275616B1/ko active IP Right Grant
- 2014-01-27 PT PT147045322T patent/PT2951172T/pt unknown
- 2014-01-27 US US14/763,594 patent/US9682963B2/en active Active
- 2014-01-27 WO PCT/EP2014/051546 patent/WO2014118133A1/en active Application Filing
- 2014-01-27 EP EP14704532.2A patent/EP2951172B8/en active Active
- 2014-01-27 CN CN201480010186.7A patent/CN105026387B/zh active Active
- 2014-01-27 BR BR112015018168-6A patent/BR112015018168B1/pt active IP Right Grant
- 2014-01-27 ES ES14704532.2T patent/ES2629762T3/es active Active
- 2014-01-27 SG SG11201505867PA patent/SG11201505867PA/en unknown
- 2014-01-27 PL PL14704532T patent/PL2951172T3/pl unknown
- 2014-01-27 EA EA201591371A patent/EA029653B1/ru unknown
- 2014-01-27 RS RS20170620A patent/RS56089B1/sr unknown
-
2015
- 2015-08-04 IL IL240363A patent/IL240363B/en active IP Right Grant
-
2016
- 2016-03-30 HK HK16103655.2A patent/HK1215706A1/zh unknown
-
2017
- 2017-05-15 US US15/595,219 patent/US9850234B2/en active Active
- 2017-06-20 HR HRP20170940TT patent/HRP20170940T1/hr unknown
- 2017-06-28 CY CY20171100684T patent/CY1119227T1/el unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20170940T1 (hr) | Derivati piridina kao lako razgradivi rock inhibitori | |
| IL245660A0 (en) | History of aminopyridines as tam family kinase inhibitors | |
| EP2952278A4 (en) | FOREST | |
| GB2534272B (en) | Rotationally-independent wellbore ranging | |
| HK1211938A1 (en) | Novel pyridine derivatives | |
| ZA201507657B (en) | Pyridin-4-yl derivatives | |
| IL245443A0 (en) | Disubstituted pyridine derivatives are useful as gsk–3 inhibitors | |
| HK1258911A1 (zh) | 可用作c-fms激酶抑制劑的取代的吡啶衍生物 | |
| IL238391A (en) | Rock inhibitors | |
| EP2968324A4 (en) | SUBSTITUTED PYRIDONE DERIVATIVES AS PDE10 INHIBITORS | |
| HK1226072A1 (zh) | 作為bcl-3抑制劑的2-苯甲酰氨基苯甲酰胺衍生物 | |
| GB201303494D0 (en) | Novel soft rock inhibitors | |
| GB201302248D0 (en) | Reduced Length Rock Drill |